Potassium Chloride Extended-release Tablet
Product Images NDC 68001-567

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Potassium Chloride Extended-release (NDC 68001-567). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Potassium Chloride 10 Meq K 100 Count (Image 01)

Potassium Chloride 10 Meq K 100 Count (Image 01)
Potassium Chloride Extended-Release Tablets USP 750 mg (10 mEq K) oral tablets label, manufactured by Granules India Limited for BluePoint Laboratories. The label includes NDC 68001-566-00, dosage strength, quantity of 100 tablets, storage instructions, and dispensing information with safety warnings. The label features the BluePoint Laboratories logo and barcode.*
FDA Label Image

Potassium Chloride 20 Meq K 100 Count (Image 02)

Potassium Chloride 20 Meq K 100 Count (Image 02)
Label for Potassium Chloride Extended-Release Tablets USP, 1500 mg (20 mEq potassium), oral tablet form. The label indicates manufacturing by Granules India Limited and distribution by BluePoint Laboratories. The package includes 100 tablets, and the label contains dosage form, strength, storage conditions, and safety warnings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.